Filing Flows › Idexx Laboratories (IDXX) › Gross margin
Idexx Laboratories (IDXX) gross margin by quarter
Idexx Laboratories' gross margin was 62.9% in Q3 2026 (third quarter 2026), -1.1 pts from Q2 2026. Over the last 7 quarters it ranged from 60.3% (Q4 2025) to 64.0% (Q2 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 62.9% | -1.1 pts | +1.1 pts |
| Q2 2026 | 64.0% | +0.7 pts | +1.4 pts |
| Q1 2026 | 63.4% | +3.0 pts | +0.9 pts |
| Q4 2025 | 60.3% | -1.5 pts | — |
| Q3 2025 | 61.8% | -0.8 pts | — |
| Q2 2025 | 62.6% | +0.2 pts | — |
| Q1 2025 | 62.4% | — | — |
Q3 2026 at a glance
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
What is Idexx Laboratories' gross margin?
Idexx Laboratories' gross margin was 62.9% in Q3 2026 (third quarter 2026), -1.1 pts from Q2 2026.
How has Idexx Laboratories' gross margin changed?
Over the last 7 quarters it ranged from 60.3% (Q4 2025) to 64.0% (Q2 2026).